Opiant Pharmaceuticals, Inc. (OPNT)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
03-Mar-23 9:16 AM
View: 
Ellison Mark Jason Heath
Chief Development Officer
Opiant Pharmaceuticals, Inc. (OPNT) 02-Mar-23Disposition 9,680$20.00$193,600.00(83%)
11.68K to 2.0K
03-Mar-23 9:18 AM
View: 
Crystal Roger
Chief Executive Officer
Director
10% Owner
Opiant Pharmaceuticals, Inc. (OPNT) 02-Mar-23Disposition 87,106$20.00$1,742,120.00(100%)
87.11K to 0
03-Mar-23 9:25 AM
View: 
Collard Craig A
Director
Opiant Pharmaceuticals, Inc. (OPNT) 02-Mar-23Disposition 55,822$20.00$1,116,440.00(100%)
55.82K to 0
03-Mar-23 9:22 AM
View: 
Ruth Matthew R.
Chief Commercial Officer
Opiant Pharmaceuticals, Inc. (OPNT) 02-Mar-23Grant 2,000----7%
29.92K to 31.92K
03-Mar-23 9:13 AM
View: 
Skolnick Phil
Chief Scientific Officer
Opiant Pharmaceuticals, Inc. (OPNT) 02-Mar-23Disposition 23,548$20.00$470,960.00(100%)
23.55K to 0
03-Mar-23 9:03 AM
View: 
Gorman Brian
Opiant Pharmaceuticals, Inc. (OPNT) 02-Mar-23Grant 2,000----6%
31.99K to 33.99K
03-Mar-23 9:27 AM
View: 
Silver Gabrielle Alison
Director
Opiant Pharmaceuticals, Inc. (OPNT) 02-Mar-23Disposition 23,343$20.00$466,860.00(100%)
23.34K to 0
03-Mar-23 9:16 AM
View: 
Ellison Mark Jason Heath
Chief Development Officer
Opiant Pharmaceuticals, Inc. (OPNT) 02-Mar-23Grant 2,000----7%
28.43K to 30.43K
03-Mar-23 9:16 AM
View: 
Ellison Mark Jason Heath
Chief Development Officer
Opiant Pharmaceuticals, Inc. (OPNT) 02-Mar-23Disposition 2,000$20.00$40,000.00(100%)
2.0K to 0
03-Mar-23 8:57 AM
View: 
O'Toole David D
Chief Financial Officer
Opiant Pharmaceuticals, Inc. (OPNT) 02-Mar-23Grant 2,000----6%
34.25K to 36.25K
03-Mar-23 9:05 AM
View: 
Lorianne Masuoka K.
Director
Opiant Pharmaceuticals, Inc. (OPNT) 02-Mar-23Disposition 4,000$20.00$80,000.00(100%)
4.0K to 0
03-Mar-23 9:08 AM
View: 
MacDougall Ann L.
Director
Opiant Pharmaceuticals, Inc. (OPNT) 02-Mar-23Disposition 28,179$20.00$563,580.00(100%)
28.18K to 0
03-Mar-23 9:10 AM
View: 
Sinclair Michael
Director
10% Owner
Opiant Pharmaceuticals, Inc. (OPNT) 02-Mar-23Disposition 27,450$20.00$549,000.00(30%)
90.17K to 62.72K
03-Mar-23 9:22 AM
View: 
Ruth Matthew R.
Chief Commercial Officer
Opiant Pharmaceuticals, Inc. (OPNT) 02-Mar-23Disposition 31,916$20.00$638,320.00(100%)
31.92K to 0
03-Mar-23 9:03 AM
View: 
Gorman Brian
Opiant Pharmaceuticals, Inc. (OPNT) 02-Mar-23Disposition 33,990$20.00$679,800.00(100%)
33.99K to 0
03-Mar-23 9:00 AM
View: 
Thomas Thomas T.
Director
Opiant Pharmaceuticals, Inc. (OPNT) 02-Mar-23Disposition 12,375$20.00$247,500.00(100%)
12.38K to 0
03-Mar-23 9:16 AM
View: 
Ellison Mark Jason Heath
Chief Development Officer
Opiant Pharmaceuticals, Inc. (OPNT) 02-Mar-23Disposition 18,751$20.00$375,020.00(62%)
30.43K to 11.68K
03-Mar-23 9:20 AM
View: 
Daly Richard J
Director
Opiant Pharmaceuticals, Inc. (OPNT) 02-Mar-23Disposition 7,800$20.00$156,000.00(100%)
7.8K to 0
03-Mar-23 9:18 AM
View: 
Crystal Roger
Chief Executive Officer
Director
10% Owner
Opiant Pharmaceuticals, Inc. (OPNT) 02-Mar-23Grant 6,667----8%
80.44K to 87.11K
03-Mar-23 8:57 AM
View: 
O'Toole David D
Chief Financial Officer
Opiant Pharmaceuticals, Inc. (OPNT) 02-Mar-23Disposition 36,248$20.00$724,960.00(100%)
36.25K to 0
03-Mar-23 9:10 AM
View: 
Sinclair Michael
Director
10% Owner
Opiant Pharmaceuticals, Inc. (OPNT) 02-Mar-23Disposition 62,720$20.00$1,254,400.00(100%)
62.72K to 0
03-Mar-23 9:13 AM
View: 
Skolnick Phil
Chief Scientific Officer
Opiant Pharmaceuticals, Inc. (OPNT) 02-Mar-23Grant 2,000----9%
21.55K to 23.55K
31-Jan-23 4:20 PM
View: 
Gorman Brian
Opiant Pharmaceuticals, Inc. (OPNT) 27-Jan-23Sale 444$20.26$8,995.44(1%)
32.43K to 31.99K
31-Jan-23 4:17 PM
View: 
O'Toole David D
Chief Financial Officer
Opiant Pharmaceuticals, Inc. (OPNT) 27-Jan-23Sale 541$20.26$10,960.70(2%)
34.79K to 34.25K
31-Jan-23 4:21 PM
View: 
Ellison Mark Jason Heath
Chief Development Officer
Opiant Pharmaceuticals, Inc. (OPNT) 27-Jan-23Sale 610$20.26$12,358.60(3%)
19.36K to 18.75K
31-Jan-23 4:22 PM
View: 
Crystal Roger
Chief Executive Officer
Director
10% Owner
Opiant Pharmaceuticals, Inc. (OPNT) 27-Jan-23Sale 1,358$20.26$27,513.10(2%)
76.7K to 75.34K
31-Jan-23 4:19 PM
View: 
Skolnick Phil
Chief Scientific Officer
Opiant Pharmaceuticals, Inc. (OPNT) 27-Jan-23Sale 480$20.26$9,724.80(2%)
22.03K to 21.55K
09-Jan-23 5:13 PM
View: 
Ellison Mark Jason Heath
Chief Development Officer
Opiant Pharmaceuticals, Inc. (OPNT) 09-Jan-23Sale 469$20.20$9,473.80(2%)
19.83K to 19.36K
09-Jan-23 5:09 PM
View: 
Crystal Roger
Chief Executive Officer
Director
10% Owner
Opiant Pharmaceuticals, Inc. (OPNT) 09-Jan-23Sale 1,183$20.20$23,896.60(2%)
77.88K to 76.7K
09-Jan-23 5:11 PM
View: 
Skolnick Phil
Chief Scientific Officer
Opiant Pharmaceuticals, Inc. (OPNT) 09-Jan-23Sale 369$20.20$7,453.80(2%)
22.4K to 22.03K
09-Jan-23 5:16 PM
View: 
O'Toole David D
Chief Financial Officer
Opiant Pharmaceuticals, Inc. (OPNT) 09-Jan-23Sale 415$20.20$8,383.00(1%)
35.2K to 34.79K
05-Jan-23 4:56 PM
View: 
Skolnick Phil
Chief Scientific Officer
Opiant Pharmaceuticals, Inc. (OPNT) 05-Jan-23Sale 1,421$20.20$28,704.20(6%)
23.82K to 22.4K
05-Jan-23 5:03 PM
View: 
O'Toole David D
Chief Financial Officer
Opiant Pharmaceuticals, Inc. (OPNT) 05-Jan-23Sale 1,600$20.20$32,320.00(4%)
36.8K to 35.2K
05-Jan-23 4:59 PM
View: 
Gorman Brian
Opiant Pharmaceuticals, Inc. (OPNT) 05-Jan-23Sale 1,313$20.20$26,522.60(4%)
33.75K to 32.43K
05-Jan-23 5:07 PM
View: 
Ellison Mark Jason Heath
Chief Development Officer
Opiant Pharmaceuticals, Inc. (OPNT) 05-Jan-23Sale 1,806$20.20$36,481.20(8%)
21.64K to 19.83K
05-Jan-23 4:52 PM
View: 
Crystal Roger
Chief Executive Officer
Director
10% Owner
Opiant Pharmaceuticals, Inc. (OPNT) 05-Jan-23Sale 5,029$20.20$101,586.00(6%)
82.91K to 77.88K
21-Jul-22 4:08 PM
View: 
Ruth Matthew R.
Chief Commercial Officer
Opiant Pharmaceuticals, Inc. (OPNT) 20-Jul-22Sale 1,084$10.62$11,512.10(3%)
31.0K to 29.92K
15-Jul-22 4:06 PM
View: 
O'Toole David D
Chief Financial Officer
Opiant Pharmaceuticals, Inc. (OPNT) 14-Jul-22Sale 779$11.10$8,646.90(2%)
37.58K to 36.8K
15-Jul-22 4:04 PM
View: 
Gorman Brian
Opiant Pharmaceuticals, Inc. (OPNT) 14-Jul-22Sale 691$11.16$7,711.56(2%)
34.44K to 33.75K
15-Jul-22 4:03 PM
View: 
Crystal Roger
Chief Executive Officer
Director
10% Owner
Opiant Pharmaceuticals, Inc. (OPNT) 14-Jul-22Sale 2,246$11.11$24,953.10(3%)
85.16K to 82.91K
15-Jul-22 4:05 PM
View: 
Skolnick Phil
Chief Scientific Officer
Opiant Pharmaceuticals, Inc. (OPNT) 14-Jul-22Sale 627$11.85$7,429.95(3%)
24.45K to 23.82K
29-Jun-22 4:02 PM
View: 
Gorman Brian
Opiant Pharmaceuticals, Inc. (OPNT) 27-Jun-22Grant 2,000----6%
32.44K to 34.44K
29-Jun-22 4:07 PM
View: 
Ellison Mark Jason Heath
Chief Development Officer
Opiant Pharmaceuticals, Inc. (OPNT) 27-Jun-22Grant 2,000----10%
19.64K to 21.64K
29-Jun-22 4:04 PM
View: 
O'Toole David D
Chief Financial Officer
Opiant Pharmaceuticals, Inc. (OPNT) 27-Jun-22Grant 2,000----6%
35.58K to 37.58K
29-Jun-22 4:06 PM
View: 
Crystal Roger
Chief Executive Officer
Director
10% Owner
Opiant Pharmaceuticals, Inc. (OPNT) 27-Jun-22Grant 6,667----8%
78.49K to 85.16K
29-Jun-22 4:03 PM
View: 
Skolnick Phil
Chief Scientific Officer
Opiant Pharmaceuticals, Inc. (OPNT) 27-Jun-22Grant 2,000----9%
22.45K to 24.45K
29-Jun-22 4:01 PM
View: 
Ruth Matthew R.
Chief Commercial Officer
Opiant Pharmaceuticals, Inc. (OPNT) 27-Jun-22Grant 2,000----7%
29.0K to 31.0K
15-Jun-22 4:30 PM
View: 
Sinclair Michael
Director
10% Owner
Opiant Pharmaceuticals, Inc. (OPNT) 15-Jun-22Sale 900$10.60$9,540.00(4%)
20.12K to 19.22K
14-Jun-22 4:51 PM
View: 
Silver Gabrielle Alison
Director
Opiant Pharmaceuticals, Inc. (OPNT) 14-Jun-22Grant 2,000----9%
21.34K to 23.34K
14-Jun-22 4:55 PM
View: 
Lorianne Masuoka K.
Director
Opiant Pharmaceuticals, Inc. (OPNT) 14-Jun-22Grant 2,000----100%
2.0K to 4.0K